Genomics

Dataset Information

33

PGRN-RIKEN: Rate Control Therapy in Patients with Atrial Fibrillation


ABSTRACT: The goal of this study was to identify genetic predictors of response to rate control therapy in patients with AF. We conducted a genome-wide association study (GWAS) focusing on subjects with a history of atrial fibrillation. Rate control therapy for AF uses a range of drugs (beta-adrenergic receptor blockers, calcium channel blockers, and digitalis) to depress conduction through the AV node, thereby preventing rapid rates and minimizing symptoms. In large groups of patients, such as the Vanderbilt AF Registry (a clinical and genetic repository with over 1200 patients with ECG-confirmed AF) from which these study subjects were drawn, approximately 5% display failure of aggressive AV nodal-blocking therapy to control ventricular rate. In these patients, interruption of the AV node by ablation and pacemaker implantation are necessary for adequate rate control. Study cases were individuals who underwent AV node ablation and pacemaker implantation after... (for more see dbGaP study page.)

PROVIDER: phs000439 | dbGaP |

SECONDARY ACCESSION(S): PRJNA80277PRJNA80275

REPOSITORIES: dbGaP

Similar Datasets

| phs000439.v1.p1 | EGA
2016-04-01 | E-GEOD-66724 | ArrayExpress
| GSE81473 | GEO
| phs001598 | dbGaP
| PRJNA80277 | ENA
| PRJNA80275 | ENA
2016-08-09 | E-GEOD-79768 | ArrayExpress
| phs000997 | dbGaP
2009-02-11 | GSE10886 | GEO
| PRJNA95395 | ENA